{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:11Z","timestamp":1791357191139,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007505","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T00:00:00Z","timestamp":1421712000000}}],"reference-count":150,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007505.pub2","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T06:06:18Z","timestamp":1421733978000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacotherapy for anxiety and comorbid alcohol use disorders"],"prefix":"10.1002","volume":"2020","author":[{"given":"Jonathan C","family":"Ipser","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo O","family":"Akindipe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carli","family":"Sager","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,20]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.janxdis.2007.03.001","article-title":"Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder","volume":"22","author":"Book","year":"2008","journal-title":"Journal of Anxiety Disorders"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1530-0277.2007.00546.x","article-title":"A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking?","volume":"32","author":"Thomas","year":"2008","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.nmd.0000235794.12794.8a","article-title":"Symptom improvement in co-occurring PTSD and alcohol dependence","volume":"194","author":"Back","year":"2006","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.ALC.0000156129.98265.57","article-title":"Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder","volume":"29","author":"Brady","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0005|cit5","unstructured":"Brady KT Sonne SC Killeen T Simpson K Randall C Back SE Sertraline in comorbid PTSD\/alcohol dependence. Proceedings of the 65th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2003 Jun 14-19; Florida 2003"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.comppsych.2004.03.015","article-title":"Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?","volume":"45","author":"Labbate","year":"2004","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007505.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1521-0391.2003.tb00484.x","article-title":"Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder","volume":"12","author":"Sonne","year":"2003","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0008|cit8","first-page":"19A","article-title":"Effect of depression on outcomes in a clinical trail evaluating antidepressants +\/- naltrexone for treatment of alcohol dependence and PTSD","volume":"37","author":"Petrakis","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/npp.2011.283","article-title":"Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence","volume":"37","author":"Petrakis","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/da.1077","article-title":"Paroxetine for social anxiety and alcohol use in dual-diagnosed patients","volume":"14","author":"Randall","year":"2001","journal-title":"Depression and Anxiety"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0011|cit11","first-page":"163","article-title":"The association of buspirone and its metabolite 1-pyrimidinylpiperazine in theremission of comorbid anxiety with depressive features and alcohol dependency","volume":"27","author":"Tollefson","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0012|cit12","first-page":"35","article-title":"Buspirone in comorbid alcohol dependency and generalized anxiety disorders","volume":"20 Suppl","author":"Tollefson","year":"1990","journal-title":"Drug Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004714-199202000-00004","article-title":"Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)","volume":"12","author":"Tollefson","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0014|cit14","first-page":"226A","article-title":"Risk-taking, impulsivity, memory and executive functioning as outcome predictors in a trial of topiramate for alcohol dependence in veterans with PTSD","volume":"36","author":"Batki","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0015|cit15","first-page":"382","article-title":"Topiramate treatment of alcohol dependence in veterans with PTSD: baseline alcohol use and PTSD severity","volume":"21","author":"Batki","year":"2011","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0016|cit16","first-page":"17A","article-title":"Predictors of outcome in a pilot controlled trial of topiramate for alcohol dependence in veterans with PTSD","author":"Batki","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.7205\/MILMED-D-13-00097","article-title":"Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder","volume":"178","author":"Kalapatapu","year":"2013","journal-title":"Military Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0018|cit18","first-page":"19A","article-title":"Urinary ethyl glucuronide and ethyl sulfate testing to evaluate the efficacy of topiramate treatment of alcohol dependence in veterans with PTSD","volume":"37","author":"Lasher","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"12","key":"10.1002\/14651858.CD007505.pub2-BIB0019|cit19","first-page":"731","article-title":"A double-blind clinical trial of camazepam vs bromazepam in the treatment of anxio-depressive syndrome in alcoholic patients","volume":"41","author":"Caponi","year":"1985","journal-title":"Progresso Medico"},{"issue":"11","key":"10.1002\/14651858.CD007505.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.brat.2013.08.003","article-title":"The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders","volume":"51","author":"Ciraulo","year":"2013","journal-title":"Behaviour Research and Therapy"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0021|cit21","unstructured":"Guardia J Clinical trial with ziprasidone for the treatment of psychiatric pathology, not being a severe mental disorder, associated to alcohol dependence clinicaltrials.gov\/ct2\/show\/NCT00197951"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.1994.03950090052008","article-title":"Buspirone treatment of anxious alcoholics. A placebo-controlled trial","volume":"51","author":"Kranzler","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0376-8716(93)90057-W","article-title":"Baclofen administration for the treatment of affective disorders in alcoholic patients","volume":"33","author":"Krupitsky","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0024|cit24","first-page":"18A","article-title":"Single blind placebo controlled randomized clinical trial of trazodon for alcoholism comorbid with affective disorders","volume":"37","author":"Krupitsky","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1-3","key":"10.1002\/14651858.CD007505.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0165-0327(02)00094-0","article-title":"Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration","volume":"76","author":"Liappas","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD007505.pub2-BIB0026|cit26","first-page":"291","article-title":"Anxiolytic efficacy and tolerance of tetrabamate in anxious patients abusing alcohol. Multicenter double-blind versus placebo study","volume":"12","author":"Loo","year":"1986","journal-title":"Encephale"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1530-0277.1992.tb00691.x","article-title":"A placebo-controlled trial of buspirone in anxious inpatient alcoholics","volume":"16","author":"Malcolm","year":"1992","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10550499309115941","article-title":"Alcoholic subjects with anxiety disorder: characteristics of completers and noncompleters in a pharmacologic study","volume":"2","author":"Moak","year":"1993","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0029|cit29","first-page":"331A","article-title":"Correlation pattern of alcohol use and PTSD symptoms among combat veterans in treatment for comorbid PTSD and alcohol use disorder","volume":"37","author":"Oluwadara","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007505.pub2-BIB0030|cit30","first-page":"331A","article-title":"Preliminary examination of alcoholism subtypes in PTSD and alcohol use dual diagnosis","volume":"37","author":"Roache","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0031|cit31","first-page":"137","article-title":"The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomised controlled trial","volume":"50","author":"Schad\u00e9","year":"2008","journal-title":"Tijdschrift Voor Psychiatrie"},{"issue":"5","key":"10.1002\/14651858.CD007505.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/01.ALC.0000163511.24583.33","article-title":"The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial","volume":"29","author":"Schad\u00e9","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0033|cit33","unstructured":"Farchione TJ CBT and venlafaxine treatments for anxiety in alcoholism clinicaltrials.gov\/ct2\/show\/NCT00248612"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0034|cit34","unstructured":"Sonne SC Brady KT Paroxetine treatment in outpatients with comorbid PTSD and substance dependence clinicaltrials.gov\/ct2\/show\/NCT00330239"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0035|cit35","unstructured":"Sattar P 12 week prospective double blind placebo controlled randomized trial of Seroquel SR for alcohol dependence and comorbid anxiety clinicaltrials.gov\/ct2\/show\/NCT00352469"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0036|cit36","unstructured":"Fischer B A 14-week randomized, placebo-controlled study of topiramate for alcohol use disorders in veterans with posttraumatic stress disorder clinicaltrials.gov\/ct2\/show\/NCT01408641"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0037|cit37","unstructured":"Simpson T A placebo-controlled trial of prazosin in individuals with co-occurring alcohol dependence and PTSD clinicaltrials.gov\/ct2\/show\/NCT01518972"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1530-0277.1995.tb01532.x","article-title":"A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders","volume":"19","author":"Powell","year":"1995","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0039|cit39","unstructured":"Sinha R Prazosin to reduce stress-induced alcohol\/drug craving and relapse clinicaltrials.gov\/ct2\/show\/NCT00585780"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0040|cit40","unstructured":"Ralevski E The use of prazosin for treatment of patients with alcohol dependence (AD) and post traumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/NCT00744055"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0041|cit41","unstructured":"A controlled trial of topiramate treatment for alcohol dependence in veterans with PTSD clinicaltrials.gov\/ct2\/show\/NCT01749215"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0042|cit42","unstructured":"Petrakis I Zonisamide in addition to enhanced cognitive processing therapy-C (E-CPT-C) for veterans with PTSD and comorbid alcohol dependence clinicaltrials.gov\/show\/NCT01847469"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0043|cit43","first-page":"28","article-title":"12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"420","author":"Alonso","year":"2004","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.03.010","article-title":"Gender and race\/ethnicity differences for initiation of alcohol-related service use among persons with alcohol dependence","volume":"140","author":"Alvanzo","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0046|cit46","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0047|cit47","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0048|cit48","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.nmd.0000235794.12794.8a","article-title":"Symptom improvement in co-occurring PTSD and alcohol dependence","volume":"194","author":"Back","year":"2006","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/03-2","article-title":"Quantitative analysis of sponsorship bias in economic studies of antidepressants","volume":"183","author":"Baker","year":"2003","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0052|cit52","first-page":"1","article-title":"The global burden of anxiety disorders in 2010","volume":"22","author":"Baxter","year":"2014","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007505.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11920-012-0300-0","article-title":"Treatment of co-occurring posttraumatic stress disorder and substance use disorders","volume":"14","author":"Berenz","year":"2012","journal-title":"Current Psychiatry Reports"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.150.9.1430a","article-title":"Treatment of flashbacks with naltrexone","volume":"150","author":"Bills","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0056|cit56","first-page":"187","article-title":"A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1","volume":"21","author":"Blake","year":"1990","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15288\/jsa.2000.61.267","article-title":"Rural at-risk drinkers: correlates and one-year use of alcoholism treatment services","volume":"61","author":"Booth","year":"2000","journal-title":"Journal of Studies on Alcohol"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4088\/JCP.12m08159","article-title":"Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the Netherlands Study of Depression and Anxiety (NESDA)","volume":"74","author":"Boschloo","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0306-4603(99)00017-9","article-title":"A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder","volume":"25","author":"Bowen","year":"2000","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01065866","article-title":"The association of alcoholism and anxiety","volume":"64","author":"Brady","year":"1993","journal-title":"Psychiatric Quarterly"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3233\/JRS-140616","article-title":"Ninety-three cases of alcohol dependence following SSRI treatment","volume":"26","author":"Brookwell","year":"2014","journal-title":"International Journal of Risk & Safety in Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1530-0277.2011.01540.x","article-title":"Alcohol and the human brain: a systematic review of different neuroimaging methods","volume":"35","author":"B\u00fchler","year":"2011","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.06.008","article-title":"Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"86","author":"Cohen","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.176.4.379","article-title":"Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale","volume":"176","author":"Connor","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"8 Suppl 2","key":"10.1002\/14651858.CD007505.pub2-BIB0065|cit65","first-page":"9S","article-title":"Clinical practice guidelines. Management of anxiety disorders","volume":"51","author":"Canadian Psychiatric Association","year":"2006","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"647","DOI":"10.15288\/jsad.2012.73.647","article-title":"Factors associated with first utilization of different types of care for alcohol problems","volume":"73","author":"Dawson","year":"2012","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1111\/j.1530-0277.2012.01930.x","article-title":"Differences in the profiles of DSM-IV and DSM-5 alcohol use disorders: implications for clinicians","volume":"37 Suppl 1","author":"Dawson","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"11","key":"10.1002\/14651858.CD007505.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0069|cit69","unstructured":"Deeks J Higgins J Altman D Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.1992.03480030052036","article-title":"Factors influencing the publication of research results: follow-up of applications submitted to two substantial review boards","volume":"267","author":"Dickersin","year":"1992","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/alcalc\/36.3.249","article-title":"The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders","volume":"36","author":"Driessen","year":"2001","journal-title":"Alcohol and Alcoholism"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.jcp.0000084032.22282.ff","article-title":"A randomized, double-blind, placebo-controlled, fixed-dose, multi-center study of pregabalin in patients with generalized anxiety disorder","volume":"23","author":"Feltner","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ADM.0b013e3182872718","article-title":"Concerns about pregabalin: further experience with its potential of causing addictive behaviors","volume":"7","author":"Gahr","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0075|cit75","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0077|cit77","first-page":"201","article-title":"Standardised assessment and recording of depressive symptoms","volume":"72","author":"Hamilton","year":"1969","journal-title":"Psychiatria, Neurologia, Neurochirurgia"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0078|cit78","first-page":"5","article-title":"Classification of alcohol use disorders","volume":"27","author":"Hasin","year":"2003","journal-title":"Alcohol Research & Health"},{"issue":"7","key":"10.1002\/14651858.CD007505.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0081|cit81","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0082|cit82","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/da.21937","article-title":"Generalizability of clinical trial results for generalized anxiety disorder to community samples","volume":"29","author":"Hoertel","year":"2012","journal-title":"Depression and Anxiety"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s11136-013-0573-8","article-title":"Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis","volume":"23","author":"Hofmann","year":"2013","journal-title":"Quality of Life Research"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000006.pub3","article-title":"Publication bias in clinical trials due to statistical significance or direction of trial results","author":"Hopewell","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","article-title":"Impact of Event Scale: a measure of subjective stress","volume":"41","author":"Horowitz","year":"1979","journal-title":"Psychosomatic Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007505.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.ALC.0000095635.46911.5D","article-title":"Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals","volume":"27","author":"Johnson","year":"2003","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1037\/0022-006X.56.1.85","article-title":"Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: three studies in reliability and validity","volume":"56","author":"Keane","year":"1988","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1037\/0022-006X.72.2.276","article-title":"Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up","volume":"72","author":"Kendall","year":"2004","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1037\/h0080151","article-title":"The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization","volume":"66","author":"Kessler","year":"1996","journal-title":"American Journal of Orthopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archpsyc.1997.01830160031005","article-title":"Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey","volume":"54","author":"Kessler","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007505.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"423","DOI":"10.31887\/DCNS.2011.13.4\/nkoen","article-title":"Pharmacotherapy of anxiety disorders: a critical review","volume":"13","author":"Koen","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1530-0277.1996.tb01696.x","article-title":"Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics","volume":"20","author":"Kranzler","year":"2006","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1530-0277.2011.01659.x","article-title":"Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence","volume":"36","author":"Kranzler","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archpsyc.63.9.957","article-title":"Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment","volume":"63","author":"Krystal","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1176\/ajp.147.6.685","article-title":"The relation between alcohol problems and the anxiety disorders","volume":"147","author":"Kushner","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD007505.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/01.alc.0000175072.17623.f8","article-title":"Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients","volume":"29","author":"Kushner","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0016-5085(98)70035-6","article-title":"Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass","volume":"115","author":"Kwo","year":"1998","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/070674371205700603","article-title":"Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review","volume":"57","author":"Lev-Ran","year":"2012","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2004.10.005","article-title":"Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification","volume":"29","author":"Liappas","year":"2005","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Modern Problems in Pharmacopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hup.395","article-title":"Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study","volume":"17","author":"Lubin","year":"2002","journal-title":"Human Psychopharmacology"},{"issue":"16","key":"10.1002\/14651858.CD007505.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007505.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11606-002-0038-1","article-title":"The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial","volume":"17","author":"Malcolm","year":"2002","journal-title":"Journal of General Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007505.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study","volume":"158","author":"Marshall","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/da.20176","article-title":"A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults","volume":"24","author":"Marshall","year":"2007","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpsychires.2011.03.006","article-title":"Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness","volume":"45","author":"McLean","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0109|cit109","volume-title":"Addiction Severity Index: Administration Manual","author":"McLellan","year":"1990"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cpr.2005.05.004","article-title":"The relationship between social anxiety disorder and alcohol use disorders: a critical review","volume":"25","author":"Morris","year":"2005","journal-title":"Clinical Psychology Review"},{"issue":"4","key":"10.1002\/14651858.CD007505.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/156720208786413415","article-title":"Consequences of alcohol consumption on neurotransmitters - an overview","volume":"5","author":"Mukherjee","year":"2008","journal-title":"Current Neurovascular Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0113|cit113","unstructured":"National Institute for Health and Care Excellence Clinical Guideline 31 Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder, 2005 www.nice.org.uk\/guidance\/cg031"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jclp.10124","article-title":"A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale","volume":"59","author":"Oakman","year":"2003","journal-title":"Journal of Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000117423.05703.e7","article-title":"Efficacy of the novel anxiolytic pregabalin in social anxiety disorder","volume":"24","author":"Pande","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5414\/CP201881","article-title":"Pregabalin abuse after past substance-seeking behavior","volume":"51","author":"Papazisis","year":"2013","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD007505.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2006.03.074","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder","volume":"60","author":"Petrakis","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007505.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1530-0277.2000.tb04648.x","article-title":"Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype","volume":"24","author":"Pettinati","year":"2000","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.jcp.0000155820.74832.b0","article-title":"Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing","volume":"25","author":"Pohl","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1530-0277.1993.tb05219.x","article-title":"Project MATCH (Matching Alcoholism Treatment to Client Heterogeneity): rationale and methods for a multisite clinical trial matching patients to alcoholism treatment","volume":"17","author":"Project MATCH","year":"1993","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"2","key":"10.1002\/14651858.CD007505.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1530-0277.2001.tb02201.x","article-title":"Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments","volume":"25","author":"Randall","year":"2001","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"19","key":"10.1002\/14651858.CD007505.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0123|cit123","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"9","key":"10.1002\/14651858.CD007505.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","volume":"62","author":"Rickels","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007505.pub2-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010204","article-title":"Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder","author":"Roberts","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD007505.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/alcalc\/agg062","article-title":"Do comorbid anxiety disorders in alcohol-dependent patients need specific treatment to prevent relapse?","volume":"38","author":"Schad\u00e9","year":"2003","journal-title":"Alcohol and Alcoholism"},{"issue":"5","key":"10.1002\/14651858.CD007505.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/01.ALC.0000163511.24583.33","article-title":"The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial","volume":"29","author":"Schad\u00e9","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"12","key":"10.1002\/14651858.CD007505.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1360-0443.1988.tb02551.x","article-title":"Alcoholism, anxiety and depression","volume":"83","author":"Schuckit","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00228-010-0853-y","article-title":"A signal for an abuse liability for pregabalin - results from the Swedish spontaneous adverse drug reaction reporting system","volume":"66","author":"Schwan","year":"2010","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198603133141121","article-title":"Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use","volume":"314","author":"Schweizer","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1017\/S0033291701004548","article-title":"Deaths from antidepressants in England and Wales 1993-1997: analysis of a new national database","volume":"31","author":"Shah","year":"2001","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter collaborative Panic Disorder Severity Scale","volume":"154","author":"Shear","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11 Suppl 3","author":"Sheehan","year":"1996","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0135|cit135","first-page":"414","article-title":"Anxiety and alcohol use disorders: comorbidity and treatment considerations","volume":"34","author":"Smith","year":"2012","journal-title":"Alcohol Research"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption: Psychological and Biological Methods","author":"Sobell","year":"1992"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addbeh.2013.08.014","article-title":"Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress","volume":"39","author":"Sofuoglu","year":"2014","journal-title":"Addictive Behaviors"},{"issue":"10","key":"10.1002\/14651858.CD007505.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4100","article-title":"Publication and related biases","volume":"4","author":"Song","year":"2000","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0139|cit139","volume-title":"Instructional Manual for the Structured Clinical Interview for DSM-IV","author":"Spitzer","year":"1996"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD007505.pub2-BIB0140|cit140","first-page":"25","article-title":"Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines","volume":"14","author":"Stein","year":"2009","journal-title":"CNS Spectrums"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-0-387-74290-8_13","volume-title":"Anxiety and Substance Use Disorders: the Vicious Cycle of Comorbidity. Series in Anxiety and Related Disorders","author":"Stewart","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1530-0277.2007.00546.x","article-title":"A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking?","volume":"32","author":"Thomas","year":"2008","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1002\/14651858.CD007505.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","article-title":"Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis","volume":"78","author":"Torrens","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1002\/14651858.CD007505.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4088\/JCP.v62n1105","article-title":"Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Tucker","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.v68n0204","article-title":"Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Tucker","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HRP.0b013e31827fd8aa","article-title":"The importance of quality of life in patients with alcohol abuse and dependence","volume":"21","author":"Ugochukwu","year":"2013","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0147|cit147","volume-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"key":"10.1002\/14651858.CD007505.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4088\/JCP.v69n1011","article-title":"Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"69","author":"Vesga-L\u00f3pez","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007505.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Sherbourne","year":"1992","journal-title":"Medical Care"},{"issue":"8","key":"10.1002\/14651858.CD007505.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/appi.ps.56.8.913","article-title":"Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder","volume":"56","author":"Watkins","year":"2005","journal-title":"Psychiatric Services"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007505.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T04:19:38Z","timestamp":1647577178000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007505.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,20]]},"references-count":150,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007505.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,20]]}}}